TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Assessment of biocompatibility after 30 days of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral Health-Related Quality of Life Scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: PET imaging with [18F]fluorodopa uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: metabolic activity of brain recorded with MRI scanner
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: amplitude of EEG event related potentials of brain cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: latency of EEG event related potentials of brain cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: EEG power in the beta-band
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mortality rate of COPD patients
Endpoint domain: Mortality/survival
Primary endpoint: Radiological progression of scoliosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: success rate at 1st attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of respiratory pauses between S1 and S2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Composite MATRICS Consensus Cognitive Battery Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success of endoscopic retrograde cholangiopancreatography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Area Under the Response Curve for FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Depression reported by parents
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Probability of Motor Block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sensitivity and specificity of modalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Requirements of propofol and remifentanil
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predicted Annual Rate of Change in 10-year Risk of Fatal or Nonfatal Heart Attack or Stroke
Endpoint domain: Mortality/survival
Primary endpoint: Disability Assessment for Dementia (DAD) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Adherence of recruited participants
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility of the investigating procedure
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility of the mobilization intervention from posterior-to-anterior on thoracic vertebrae
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility of the mobilization intervention from anterior-to-posterior on thoracic vertebrae
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Visual analogical scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Computer Cognitive Test Scores - ImPACT Verbal Memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Posttraumatic Stress Disorder Checklist - Military Version (PCL-M) Scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Computer Cognitive Test Scores - ImPACT Processing Speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline in speed of walking over a one week period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in number of steps taken over a one week period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in length of stride over a one week period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subject survival
Endpoint domain: Mortality/survival
Primary endpoint: Freedom from major amputation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Achieving NKF-K/DOQI targets for biPTH and Ca x P
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in Pain on Movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to AF recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cmax,ss(76h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative PAR level(73h,%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mouse allergic status confirmation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Amount of alcohol and drug use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With a > 30% Decrease From Baseline in Mean PTH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Left Ventricular Assist Device (LVAD) Knowledge Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: reduction of HL recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of Major Stroke or Neurological Death
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of Complete Aneurysm Occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: death frequency
Endpoint domain: Mortality/survival
Primary endpoint: Point prevalence of COVID-19 infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: percentage of time spent in the BIS interval [40-60]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thrombotic Events
Endpoint domain: Adverse events/effects
Primary endpoint: Safety profile of istradefylline
Endpoint domain: Adverse events/effects
Primary endpoint: Area Under the Plasma Concentration-time Curve at Steady State (AUCτ,ss)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in self-reported number of non-condom-protected anal and vaginal sex acts (3-month follow-up)
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Change in self-reported number of non-condom-protected anal and vaginal sex acts (6-month follow-up)
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Endo-PAT RHI value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: App usage ratio during intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: fasting blood glucose concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time to achieve 800ml/day feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite rate of death, myocardial infarction (MI), urgent target vessel revascularization (TVR) within 30 days or in-hospital major bleeding
Endpoint domain: Mortality/survival
Primary endpoint: Patient Counts of Ng Plus Ct Plus Syphilis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Gaining weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean Drinks Per Day at Baseline vs. Visit 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Percent Days Abstinent Per Week at Baseline vs. Visit 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Binge Eating Episodes Per Week at Baseline vs. Visit 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in obstructive sleep apnea (OSA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: CNC Monosyllabic Word Performance - Treated Ear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impairment by pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of patients contacted and recruited
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of GP practices contacted and recruited
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Retention rate of patients
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Immunogenicity of H1N1 vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Inspiratory transpulmonary pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Expiratory transpulmonary pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Systemic Treatment Choice
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: failure-free survival (FFS)
Endpoint domain: Mortality/survival
Primary endpoint: Oral chemotherapy compliance
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of cases tested positive for B.Pertussis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of cases tested positive given by anti-pertussis toxin IgG level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: UCLA PTSD RI DSM-5 Total Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dermal response score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: LRP onset latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Multiparameters diagnostic concordance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability and usability of Snore PAP system
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change From Baseline OSDI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline Tear Osmolarity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline TBUT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of Maximum Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under Curve (AUC0-72)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Swallowing disturbance severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolic clearance rate of glucagon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Noise levels in decibels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Workplace Sedentary Time
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean change in insulin sensitivity measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean change in mitochondrial function of the electron transport system measured by complex I activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Range of movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Discrimination of inflammatory and infectious arthritis using proteic markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Discrimination of inflammatory and infectious arthritis using cytokine markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Discrimination of inflammatory and infectious arthritis using cellular markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: BMI Z Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline to Month 1 in Wake After Sleep Onset (WASO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline to Month 3 in Wake After Sleep Onset (WASO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline to Month 1 in Latency to Persistent Sleep (LPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline to Month 3 in Latency to Persistent Sleep (LPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in number of opioid prescriptions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Glycosylated Haemoglobin A1c at Start
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glycosylated Haemoglobin A1c at 6 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Clinical Response Rate at 3 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Response Rate at 6 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: event-free survival rate at 12 months
Endpoint domain: Mortality/survival
Primary endpoint: Change in post-operative narcotic usage
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Changes in the Eating Disorder Examination Questionnaire (EDE-Q-I)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in the Clinical Impairment Assessment (CIA) questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in the Night Eating Questionnaire (NEQ)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Changes in the treatment Outcome Questionnaire-45 (OQ-45)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Compliance to the nutritional instructions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Neutrophil count in induced sputum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Failure of cranioplasty implant
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical Response (Partial Response + Complete Response)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: potassium concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Accuracy of LS BioPath TOUCH device
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve (AUC) 0-48h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve (AUC) 0-6h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of torque demand to capacity ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Under-triage rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tracheobronchial angles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Participants With Adverse Events That Meet Dose-limiting Toxicity (DLT) Criteria
Endpoint domain: Adverse events/effects
Primary endpoint: Change in ADHD symptoms with Quotient ADHD System assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in assessment of ADHD symptoms with Conners 3-Parent rating scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bioavailability of E5501
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GCF Activin-A levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change in Biomarker Fetal Hemoglobin (HbF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change in Proportion of Days Covered (PDC) by Hydroxyurea
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Power spectral change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cortical excitability alteration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: DaTscan intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: combined symptom medication score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Subjective cure rate of prolapse
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Accuracy of hybrid image technology guided biopsies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Sensory and motor block level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of falls and fallers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hip fractures and hospitalizations rates due to falls
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Absorbed radiation dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heating Rate at 1 cm Depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heating Rate at 1.75 cm Depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heating Rate at 2.5 cm Depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Calcineurin Inhibitor Toxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Local reactions after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Systemic reactions after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Perception of joint pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Recanalization or reflux of the treated venous trunk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Total Intubation Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in total hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in functional connectivity strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in Gamma H2AX Positivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Changes in Circulating Prostate Cancer Cell Numbers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Posture at work environment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aortic Injury-related Mortality
Endpoint domain: Mortality/survival
Primary endpoint: Time Weighted Average Verbal Response Scale Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Response (CR and PR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of Pyelonephritis
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of diabetes and prediabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: bile leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal tolerated dose of yttrium Y 90
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Toxicity profile of yttrium Y 90
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of indication for dose delays
Endpoint domain: Adverse events/effects
Primary endpoint: PCR-Corrected Adequate Clinical and Parasitological Response (ACPR) Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in CAPS-IV Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence rate and severity of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Change From Baseline in Percent Body Surface Area (BSA) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mean Change From Baseline in Dermatology Life Quality Index (DLQI) Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean Change From Baseline in Psoriasis Area and Severity Index (PASI) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in Pulmonary Function (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Doppler flows
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in graft status after liver transplant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of NaF PET/MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bone defect area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: defect area dimensional changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plaque-pH modification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: L94 visual perceptual battery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FIORI scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing